 |
At GSK we unite science, technology and talent to get ahead of disease together
We prevent and treat disease with vaccines, specialty and general medicines. We are one of the world’s largest vaccines companies, with the broadest portfolio of vaccines on the market and a strong pipeline of vaccines in development. We supply more than 20 vaccines to more than 160 countries to help protect people from a range of diseases throughout their lives. Our vaccines help prevent illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, pneumococcal disease, influenza, shingles and meningitis. Our pipeline is underpinned by a broad portfolio of technology platforms, including mRNA, that will ensure we continue to deliver highly innovative vaccines.
For further information, please visit the website.
|
|
|
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that
focuses on the discovery, development and commercialisation of prescription medicines in
Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and
Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries
and its innovative medicines are used by millions of patients worldwide. Please visit the website
and follow the Company on Twitter @AstraZeneca.
|
